AGL logo

agilon health, inc. Stock Price

NYSE:AGL Community·US$1.3b Market Cap
  • 3 Narratives written by author
  • 1 Comments on narratives written by author
  • 18 Fair Values set on narratives written by author

AGL Share Price Performance

US$86.39
86.39 (0.00%)
US$19.67
Fair Value
US$86.39
86.39 (0.00%)
339.2% overvalued intrinsic discount
US$19.67
Fair Value
Price US$86.39
AnalystConsensusTarget US$19.67
AnalystLowTarget US$6.25
AnalystHighTarget US$95.00

AGL Community Narratives

·
Fair Value US$19.67 339.2% overvalued intrinsic discount

Analyst Price Target for agilon health Rises Amid Leadership Changes and Updated Profit Margin Forecasts

0users have liked this narrative
1users have commented on this narrative
10users have followed this narrative
·
Fair Value US$6.25 1.3k% overvalued intrinsic discount

Healthcare Execution Flaws And Margin Pressures Will Yield Modest Turnaround

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
·
Fair Value US$95 9.1% undervalued intrinsic discount

Aging Population And Value-Based Care Will Expand Opportunities

0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative

Trending Discussion

Updated Narratives

AGL logo

AGL: Reverse Stock Split And Upgraded Outlook Will Support Future Upside

Fair Value: US$95 9.1% undervalued intrinsic discount
1 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
AGL logo

AGL: Reverse Stock Split Will Sustain Pressure On Future Share Returns

Fair Value: US$6.25 1.3k% overvalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
AGL logo

AGL: Reverse Stock Split Will Expose Downside Risk To 2026 Outlook

Fair Value: US$19.67 339.2% overvalued intrinsic discount
10 users have set this as their fair value
1 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Undervalued with excellent balance sheet.

1 Risk
3 Rewards

agilon health, inc. Key Details

US$5.8b

Revenue

US$6.0b

Cost of Revenue

-US$145.7m

Gross Profit

US$227.8m

Other Expenses

-US$373.5m

Earnings

Last Reported Earnings
Mar 31, 2026
Next Reporting Earnings
n/a
-22.39
-2.50%
-6.42%
16.5%
View Full Analysis

About AGL

Founded
2016
Employees
856
CEO
Timothy O’Rourke
WebsiteView website
www.agilonhealth.com

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Westerville, Ohio.

Recent AGL News & Updates

Narrative Update May 22

AGL: Reverse Stock Split And Upgraded Outlook Will Support Future Upside

Analysts have increased their price target for agilon health to $95.00, citing updated assumptions for fair value, discount rate, revenue growth, profit margin, and future P/E as the key factors behind the revision. What's in the News agilon health issued earnings guidance for the first quarter ending March 31, 2026, with expected total revenues between US$1,350 million and US$1,390 million, and for the 2026 fiscal year with expected total revenues between US$5,410 million and US$5,580 million (Company guidance).

Recent updates

No updates